Sangamo BioSciences Inc.
Q1 2012 Earnings Call
May 2, 2012; 05:00pm ET
ExecutivesEdward Lanphier - President & Chief Executive Office Ward Wolffe - Executive Vice President & Chief Financial Officer Geoff Nichol - Executive Vice President of Research & Development Philip Gregory - Vice President of Research & Scientifics, Chief Scientific Officer Dale Ando - Vice President of Development & Chief Medical Officer Elizabeth Wolffe - Senior Director of Corporate Communications Analysts Charles Duncan - JMP Securities Liana Moussatos - Wedbush Securities Joseph Schwartz - Leerink Swann
Previous Statements by SGMO
» Sangamo BioSciences' CEO Discusses Q4 2011 Results - Earnings Call Transcript
» Sangamo BioSciences' CEO Presents at the 30th Annual J.P. Morgan Healthcare Conference (Transcript)
» Sangamo BioSciences at Lazard Capital Markets 8th Annual Healthcare Conference Call Transcript
» Sangamo BioSciences CEO Discusses Q3 2011 Results - Earnings Call Transcript
Following this introduction, Edward will highlight recent activities and the significant events from the past quarter. Ward will then briefly review the first quarter financial results, as well as our financial guidance for 2012. Geoff will provide an update on our ZFP therapeutic programs, and finally Edward will update you on our goals for the rest of 2012. Following that we will open up the call for questions.